ES2184633B1 - Procedimiento para la preparacion de derivados de 4-(imidazol-1-il) bencenosulfonamida. - Google Patents

Procedimiento para la preparacion de derivados de 4-(imidazol-1-il) bencenosulfonamida.

Info

Publication number
ES2184633B1
ES2184633B1 ES200101853A ES200101853A ES2184633B1 ES 2184633 B1 ES2184633 B1 ES 2184633B1 ES 200101853 A ES200101853 A ES 200101853A ES 200101853 A ES200101853 A ES 200101853A ES 2184633 B1 ES2184633 B1 ES 2184633B1
Authority
ES
Spain
Prior art keywords
imidazol
formula
preparation
derivatives
bencenosulfonamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES200101853A
Other languages
English (en)
Other versions
ES2184633A1 (es
Inventor
Carmen Almansa Rosales
Concepcion Gonzalez Gonzalez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noucor Health SA
Original Assignee
J Uriach y Cia SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES200101853A priority Critical patent/ES2184633B1/es
Application filed by J Uriach y Cia SA filed Critical J Uriach y Cia SA
Priority to CA2456531A priority patent/CA2456531C/en
Priority to US10/485,950 priority patent/US7351836B2/en
Priority to KR1020047001749A priority patent/KR100888905B1/ko
Priority to EP02794802A priority patent/EP1424329B1/en
Priority to BRPI0211749A priority patent/BRPI0211749B8/pt
Priority to PT02794802T priority patent/PT1424329E/pt
Priority to DK02794802T priority patent/DK1424329T3/da
Priority to JP2003521211A priority patent/JP4309262B2/ja
Priority to ES02794802T priority patent/ES2307817T3/es
Priority to PCT/ES2002/000385 priority patent/WO2003016285A1/es
Priority to DE60226879T priority patent/DE60226879D1/de
Priority to AT02794802T priority patent/ATE396976T1/de
Priority to MXPA04001147A priority patent/MXPA04001147A/es
Priority to ARP020102972A priority patent/AR037231A1/es
Publication of ES2184633A1 publication Critical patent/ES2184633A1/es
Priority to NO20040981A priority patent/NO326162B1/no
Publication of ES2184633B1 publication Critical patent/ES2184633B1/es
Application granted granted Critical
Priority to HK04109044A priority patent/HK1066214A1/xx
Priority to US12/060,574 priority patent/US8476456B2/en
Priority to CY20081100892T priority patent/CY1108861T1/el
Priority to ARP120101436A priority patent/AR086065A2/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/39—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/40—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68—Halogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Procedimiento para la preparación de derivados de 4-(imidazol-1- il) bencenosulfonamida de fórmula I, donde R1 representa arilo o heteroarilo opcionalmente sustituido, caracterizado porque comprende tratar un compuesto de fórmula II, donde R1 tiene el mismo significado descrito para la fórmula I y But representa tert-butilo, con un ácido adecuado. Los derivados de 4(imidazol- 1-il) bencenosulfonamida de fórmula I son útiles como agentes antiinflamatorios.
ES200101853A 2001-08-07 2001-08-07 Procedimiento para la preparacion de derivados de 4-(imidazol-1-il) bencenosulfonamida. Expired - Fee Related ES2184633B1 (es)

Priority Applications (20)

Application Number Priority Date Filing Date Title
ES200101853A ES2184633B1 (es) 2001-08-07 2001-08-07 Procedimiento para la preparacion de derivados de 4-(imidazol-1-il) bencenosulfonamida.
AT02794802T ATE396976T1 (de) 2001-08-07 2002-08-01 Verfahren zur herstellung von 4-(imidazol-1- yl)benzolsulfonamidderivaten
KR1020047001749A KR100888905B1 (ko) 2001-08-07 2002-08-01 4-(이미다졸-1-일)벤젠술폰아미드 유도체의 제조 방법
EP02794802A EP1424329B1 (en) 2001-08-07 2002-08-01 Process for the preparation of 4-(imidazol-1-yl)benzenesulfonamide derivatives
BRPI0211749A BRPI0211749B8 (pt) 2001-08-07 2002-08-01 processo para a preparação de derivados de 4-(imidazol-1- il)benzenossulfonamida
PT02794802T PT1424329E (pt) 2001-08-07 2002-08-01 Processo de preparação de derivados de 4-(imidazol-1-il) benzenossulfonamida
DK02794802T DK1424329T3 (da) 2001-08-07 2002-08-01 Fremgangsmåde til fremstillingen af 4-(imidazol-1-yl)benzensulfonamid
US10/485,950 US7351836B2 (en) 2001-08-07 2002-08-01 Method of preparing 4-(imidazol-1-yl)benzenesulphonamide derivatives
ES02794802T ES2307817T3 (es) 2001-08-07 2002-08-01 Procedimiento para la preparacion de derivados de 4-(imidazol-1-il)bencenosulfanomida.
PCT/ES2002/000385 WO2003016285A1 (es) 2001-08-07 2002-08-01 Procedimiento para la preparacion de derivados de 4-(imidazol-1-il)bencenosulfonamida
CA2456531A CA2456531C (en) 2001-08-07 2002-08-01 Process for the preparation of 4-(imidazole-1-yl)benzenesulfonamide derivatives
DE60226879T DE60226879D1 (de) 2001-08-07 2002-08-01 Verfahren zur herstellung von 4-(imidazol-1-yl)benzolsulfonamidderivaten
JP2003521211A JP4309262B2 (ja) 2001-08-07 2002-08-01 ４−（イミダゾール−１−イル）ベンゼンスルホンアミド誘導体の製造方法
MXPA04001147A MXPA04001147A (es) 2001-08-07 2002-08-01 Procedimiento para la preparacion de derivados de 4-(imidazol-1-il)bencenosulfonamida.
ARP020102972A AR037231A1 (es) 2001-08-07 2002-08-06 Procedimiento para la preparacion de derivados de 4-(imidazol-1-il) bencenosulfonamida e compuestos intermedios para la obtencion de los mismos
NO20040981A NO326162B1 (no) 2001-08-07 2004-03-05 Fremgangsmate for fremstilling av 4-(imidazol-1-yl)benzensulfonamidderivater.
HK04109044A HK1066214A1 (en) 2001-08-07 2004-11-17 Process for the preparation of 4-(imidazol-1-yl) benzenesulfonamide derivatives
US12/060,574 US8476456B2 (en) 2001-08-07 2008-04-01 Process for the preparation of 4-(imidazol-1-yl)benzenesulfonamide derivatives
CY20081100892T CY1108861T1 (el) 2001-08-07 2008-08-21 Μεθοδος δια την παρασκευη παραγωγων 4-(ιμιδαζολ-1-υλ)-βενζολοσουλφοναμιδης
ARP120101436A AR086065A2 (es) 2001-08-07 2012-04-25 Compuestos de imidazolsulfonamidas y un proceso para su produccion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200101853A ES2184633B1 (es) 2001-08-07 2001-08-07 Procedimiento para la preparacion de derivados de 4-(imidazol-1-il) bencenosulfonamida.

Publications (2)

Publication Number Publication Date
ES2184633A1 ES2184633A1 (es) 2003-04-01
ES2184633B1 true ES2184633B1 (es) 2004-08-01

Family

ID=8498662

Family Applications (2)

Application Number Title Priority Date Filing Date
ES200101853A Expired - Fee Related ES2184633B1 (es) 2001-08-07 2001-08-07 Procedimiento para la preparacion de derivados de 4-(imidazol-1-il) bencenosulfonamida.
ES02794802T Expired - Lifetime ES2307817T3 (es) 2001-08-07 2002-08-01 Procedimiento para la preparacion de derivados de 4-(imidazol-1-il)bencenosulfanomida.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES02794802T Expired - Lifetime ES2307817T3 (es) 2001-08-07 2002-08-01 Procedimiento para la preparacion de derivados de 4-(imidazol-1-il)bencenosulfanomida.

Country Status (17)

Country Link
US (2) US7351836B2 (es)
EP (1) EP1424329B1 (es)
JP (1) JP4309262B2 (es)
KR (1) KR100888905B1 (es)
AR (2) AR037231A1 (es)
AT (1) ATE396976T1 (es)
BR (1) BRPI0211749B8 (es)
CA (1) CA2456531C (es)
CY (1) CY1108861T1 (es)
DE (1) DE60226879D1 (es)
DK (1) DK1424329T3 (es)
ES (2) ES2184633B1 (es)
HK (1) HK1066214A1 (es)
MX (1) MXPA04001147A (es)
NO (1) NO326162B1 (es)
PT (1) PT1424329E (es)
WO (1) WO2003016285A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2638537C2 (ru) 2012-07-12 2017-12-14 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Ингибирование ферментов
WO2022269384A1 (en) * 2021-06-24 2022-12-29 Ami Organics Ltd. A process for the direct synthesis of fedratinib intermediate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TNSN99111A1 (fr) * 1998-06-11 2005-11-10 Pfizer Derives de sulfonylbenzene nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
AU5458199A (en) * 1998-07-02 2000-01-24 Cryptography Research, Inc. Leak-resistant cryptographic indexed key update
AR024222A1 (es) * 1998-10-16 2002-09-25 Palau Pharma Sa Imidazoles con actividad antiinflamatoria un procedimiento para su preparacion y composiciones farmaceuticas que lo contienen
ES2159489B1 (es) 2000-03-23 2002-04-16 Uriach & Cia Sa J Nuevos derivados de imidazol con actividad antiinflamatoria.

Also Published As

Publication number Publication date
HK1066214A1 (en) 2005-03-18
CY1108861T1 (el) 2014-08-13
AR037231A1 (es) 2004-11-03
BRPI0211749B8 (pt) 2021-05-25
US20040242872A1 (en) 2004-12-02
US20090012307A1 (en) 2009-01-08
US7351836B2 (en) 2008-04-01
NO326162B1 (no) 2008-10-13
BR0211749A (pt) 2004-10-13
US8476456B2 (en) 2013-07-02
AR086065A2 (es) 2013-11-13
BR0211749B1 (pt) 2013-09-10
EP1424329A1 (en) 2004-06-02
WO2003016285A1 (es) 2003-02-27
ES2307817T3 (es) 2008-12-01
PT1424329E (pt) 2008-08-06
CA2456531A1 (en) 2003-02-27
DK1424329T3 (da) 2008-09-29
JP2005502659A (ja) 2005-01-27
DE60226879D1 (de) 2008-07-10
CA2456531C (en) 2010-12-14
NO20040981L (no) 2004-03-05
JP4309262B2 (ja) 2009-08-05
ES2184633A1 (es) 2003-04-01
KR100888905B1 (ko) 2009-03-16
MXPA04001147A (es) 2004-07-08
KR20040020079A (ko) 2004-03-06
WO2003016285A8 (es) 2003-08-28
EP1424329B1 (en) 2008-05-28
ATE396976T1 (de) 2008-06-15

Similar Documents

Publication Publication Date Title
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
CY1109886T1 (el) Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
ATE433447T1 (de) Pyrimiidinverbindungen
DE69817802D1 (de) Substituierte phenylderivate, ihre herstellung und verwendung
DE602006016313D1 (de) Biphenylderivate und ihre verwendung bei der behandlung von hepatitis c
DE60236600D1 (de) Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung
NO20005237D0 (no) Heterocyklisk substituerte amider anvendt som calpain- inhibitorer
BR9900177A (pt) Inibidores de metaloprotease.
CY1105797T1 (el) Ν-αρυλ-2-οχαζολιδινονο-5-καρβοξαμιδια και παραγωγα αυτων και χρηση αυτων σαν αντιβιοτικα
CY1105915T1 (el) Παραγωγα θειαζολιου για τη θepαπεια των παθησεων που σχετιζονται με τους ppar
CY1106598T1 (el) Παραγωγα κινολινης και ισοκινολινης, μεθοδος για την παραγωγη αυτων και χρηση αυτων ως αντιφλεγμονωδη μεσα
CY1106801T1 (el) Νεες ετεροκυκλικες ενωσεις, η παρασκευη τους και η χρηση τους ως φαρμακα, ιδιαιτερα ως αντιβακτηριακα
TR200200068T2 (tr) Nematisital triflüorobütenler
CY1108254T1 (el) Ενωσεις που επηρεαζουν τη γλυκοκιναση
ES2243579T3 (es) Derivados de pirazolopirideno.
EA200000826A1 (ru) Галоидированные производные амидиноаминокислот, применимые в качестве ингибиторов no-синтазы
ATE347555T1 (de) 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung
UY27338A1 (es) Nuevos derivados de ácido sulfónico
DE60116589D1 (de) Fungizide Phenylamidinderivative
CY1105345T1 (el) Φαινυλαλκινια
ATE353884T1 (de) Multifunktionelle kationische photoinitiatoren, deren herstellung und verwendung
TR200200745T2 (tr) Fenilasetik asit türevleri için proses.
ES2184633B1 (es) Procedimiento para la preparacion de derivados de 4-(imidazol-1-il) bencenosulfonamida.
ES2185196T3 (es) Un procedimiento para la preparacion de tetraazamacrociclos.
ATE276259T1 (de) Dihydroporphyrinderivate und ihre verwendung

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20030401

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2184633B1

Country of ref document: ES

FD2A Announcement of lapse in spain

Effective date: 20211118